Observational studyMolecular cancer2024

RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study.

Blessie Elizabeth Nelson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.